Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer

Baird, R, Oliveira, M, Ciruelos Gil, EM et al. (33 more authors) (2021) Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer. In: 2020 San Antonio Breast Cancer Virtual Symposium, 08-11 Dec 2020, San Antonio, Texas, USA.

Metadata

Authors/Creators:
  • Baird, R
  • Oliveira, M
  • Ciruelos Gil, EM
  • Patel, MR
  • Bermejo de las Heras, B
  • Ruiz-Borrego, M
  • Garcia-Corbacho, J
  • Armstrong, A
  • Banerji, U
  • Twelves, C
  • Boni, V
  • Incorvati, J
  • Kabos, P
  • Cohen, AL
  • de Paula, B
  • Rodriguez, MC
  • Wang, JS
  • Hernando, C
  • Falcon Gonzalez, A
  • Victoria Ruiz, I
  • Lai-Kwon, J
  • Afghani, A
  • Vaklavas, C
  • Brier, T
  • Fox, S
  • Kirova, B
  • Klinowska, T
  • Leach, C
  • Lindemann, JPO
  • Mather, R
  • Maudsley, R
  • Morrow, CJ
  • Sathiyayogan, N
  • Sykes, A
  • Zhang, L
  • Hamilton, E
Dates:
  • Published: February 2021
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 30 Mar 2021 12:15
Last Modified: 30 Mar 2021 12:15
Status: Published
Identification Number: https://doi.org/10.1158/1538-7445.SABCS20-PS11-05
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)